spiraprilat has been researched along with angiotensin i in 2 studies
| Studies (spiraprilat) | Trials (spiraprilat) | Recent Studies (post-2010) (spiraprilat) | Studies (angiotensin i) | Trials (angiotensin i) | Recent Studies (post-2010) (angiotensin i) |
|---|---|---|---|---|---|
| 20 | 7 | 0 | 4,218 | 125 | 1,253 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, KL; Barnhill, MA; Brooks, DE; Frazier, D; Laratta, LJ | 1 |
| Barnett, A; Baum, T; Pula, K; Tedesco, RP; Watkins, RW | 1 |
2 other study(ies) available for spiraprilat and angiotensin i
| Article | Year |
|---|---|
Angiotensin converting enzyme system in the normal canine eye: pharmacological and physiological aspects.
Topics: Administration, Topical; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Aqueous Humor; Dogs; Eye; Intraocular Pressure; Male; Ocular Physiological Phenomena; Peptidyl-Dipeptidase A; Phenylbutyrates; Random Allocation; Renin-Angiotensin System; Spiro Compounds | 1991 |
Systemic effects resulting from topical ocular administration of SCH 33861, a novel ACE inhibitor ocular hypotensive agent.
Topics: Administration, Topical; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Heart Rate; Intraocular Pressure; Male; Phenylbutyrates; Rabbits; Spiro Compounds | 1988 |